Shares of Ligand Pharmaceuticals Incorporated (LGND) are rallying more than 21 percent Tuesday morning after reporting upbeat fourth-quarter results, above analysts' view.
Net income from continuing operations for the fourth quarter was $18.2 million, or $1.03 per share, compared with a net loss of $14.5 million, or $0.86 per share, for the same period a year ago.
Excluding special items, adjusted net income from continuing operations was $24.4 million, or $1.38 per diluted share, that beat the average estimate of analysts polled by Thomson-Reuters of $0.66 per share.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.